Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 28, 2011 16:00 ET | Source: 21st North Inc.

Urologix to Present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics and Metabolic Disorders Conference

MINNEAPOLIS, Nov. 28, 2011 (GLOBE NEWSWIRE) -- Urologix, Inc. (Nasdaq:ULGX) is the market leading medical device company for in-office procedures to treat BPH that provide safe, durable and effective...
November 10, 2011 12:00 ET | Source: 21st North Inc.

Urologix to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

MINNEAPOLIS, Nov. 10, 2011 (GLOBE NEWSWIRE) -- Urologix, Inc. (Nasdaq:ULGX), is the market leading medical device company for in-office procedures to treat BPH that provide safe, durable and effective...
November 07, 2011 16:25 ET | Source: 21st North Inc.

Urologix Reports Fiscal 2012 First Quarter Results

Addition of Prostiva RF Therapy expands customer base and addressable patient population $3.1 million in total revenue, 8% sequential revenue growth Sales force expanded with addition of...
September 06, 2011 08:38 ET | Source: 21st North Inc.

Urologix Announces Signing of an Exclusive Worldwide License for the Prostiva RF Therapy System for BPH

Urologix becomes the leading provider of in-office solutions for the early and effective treatment of obstructive urinary conditions due to benign prostatic hyperplasia (BPH) Diversifies...
August 23, 2011 16:00 ET | Source: 21st North Inc.

Urologix Reports Fiscal 2011 Fourth Quarter & Year-End Results

Revenue of $2.9 million, for the fourth quarter and $12.6 million for fiscal year 2011. A net loss of $1.3 million, or $0.09 per diluted share in the fourth quarter and $3.7 million or $0.26...
June 30, 2011 16:00 ET | Source: 21st North Inc.

Urologix Regains Compliance With Nasdaq Minimum Bid Price Requirement

MINNEAPOLIS, June 30, 2011 (GLOBE NEWSWIRE) -- Urologix, Inc. (Nasdaq:ULGX), the manufacturer and marketer of minimally invasive Cooled ThermoTherapy™ (CTT), the durable and effective in-office...
June 16, 2011 16:12 ET | Source: 21st North Inc.

Urologix Announces Hiring of Vice President, Sales and Marketing

MINNEAPOLIS, June 16, 2011 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), a medical device company that develops, manufactures and markets minimally invasive Cooled ThermoTherapy™ (CTT)...
April 26, 2011 16:00 ET | Source: 21st North Inc.

Urologix Announces Publication of Multi-Center 5 Year Durability Study of Cooled ThermoTherapy in Journal of Urology

Only 11% of patients required BPH drugs at 5 years post treatment 90% freedom from secondary procedures though 5 years MINNEAPOLIS, April 26, 2011 (GLOBE NEWSWIRE) -- Urologix®, Inc....
April 26, 2011 16:00 ET | Source: 21st North Inc.

Urologix Reports Results for Fiscal Year 2011 Third Quarter

MINNEAPOLIS, April 26, 2011 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), the manufacturer and marketer of minimally invasive Cooled ThermoTherapy™ (CTT), the durable and effective...
February 16, 2011 11:00 ET | Source: 21st North Inc.

Urologix Announces Grant of 180-Day Extension to Regain Compliance With NASDAQ Minimum Bid Price Requirement

MINNEAPOLIS, Feb. 16, 2011 (GLOBE NEWSWIRE) -- Urologix, Inc. (Nasdaq:ULGX), the manufacturer and marketer of minimally invasive Cooled ThermoTherapy™ (CTT), the durable and effective in-office...